Find your path to Paul
Sign up to see every warm intro you have to Paul
- Paths you didn't know you had: your email and LinkedIn already hold routes to Paul. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Paul Chang is an Analyst who joined Sofinnova BioEquities in 2025, where he works on public investments in medical technology and diagnostics. He previously served as an Investment Associate at TPG Growth, sourcing healthcare investments and supporting portfolio companies, and before that was an investment banker at Goldman Sachs covering healthcare M&A and financing. He holds a BS in Finance with a minor in English Literature from New York University.
Invests in
HealthtechMedical Devices
Colleagues at Sofinnova Ventures
Frequently asked questions
- Who is Paul Chang?
- Paul Chang is an Analyst who joined Sofinnova BioEquities in 2025, where he works on public investments in medical technology and diagnostics. He previously served as an Investment Associate at TPG Growth, sourcing healthcare investments and supporting portfolio companies, and before that was an investment banker at Goldman Sachs covering healthcare M&A and financing. He holds a BS in Finance with a minor in English Literature from New York University.
- Where does Paul Chang work?
- Paul Chang is Analyst, Public Equity at Sofinnova Ventures.
- What does Paul Chang invest in?
- Paul Chang invests in Healthtech, Medical Devices.
About this profile. Compiled from public sources — Sofinnova Ventures's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights







